Predictive biomarkers for immune checkpoint blockade and opportunities for combination therapies
Author:
Funder
V Foundation for Cancer Research
National Cancer Institute
Publisher
Elsevier BV
Subject
Cell Biology,Genetics (clinical),Molecular Biology,Biochemistry
Reference158 articles.
1. The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases;Coley;Clin Orthop Relat Res,1893
2. Oncology meets immunology: the cancer-immunity cycle;Chen;Immunity,2013
3. Cancer immunoediting: from immunosurveillance to tumor escape;Dunn;Nat Immunol,2002
4. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion;Schreiber;Science,2011
5. The blockade of immune checkpoints in cancer immunotherapy;Pardoll;Nat Rev Canc,2012
Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. PD-L1 mRNA and protein expression in canine mammary carcinomas: Correlation with histopathological grade and molecular markers;Veterinary Pathology;2024-01-28
2. Nucleic acid‐based small molecules as targeted transcription therapeutics for immunoregulation;Allergy;2023-12-06
3. Real‐world outcomes of 18,186 metastatic solid tumor outpatients: Baseline blood cell counts correlate with survival after immune checkpoint inhibitor therapy;Cancer Medicine;2023-11
4. Identification of the most effective subgroup of advanced hepatocellular carcinoma from immune checkpoint blocker treatment: a meta-analysis;Immunotherapy;2023-06
5. Nivolumab plus ipilimumab combination therapy in cancer: Current evidence to date;International Immunopharmacology;2023-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3